Observations with high-dose Mydocalm therapy.
The effect of coated Mydocalm tablet, given in 3 x 150-mg daily doses for 3 weeks to 47 patients, simultaneously with physiotherapy, has been examined in comparison to the results of 47 patients treated with physiotherapy solely. In the group of patients receiving Mydocalm as an adjuvant to physiotherapy the alleviation of pain and moderation of muscular hypertonia and spasm were observed within a shorter period. On the basis of the results of these examinations the use of Mydocalm is recommended as an adjuvant to complex therapy, in 300-450-mg daily doses, for the treatment of locomotor diseases accompanied by muscular hypertonia, muscular spasticity, and contracture.
Kiss
A M
AM
Sopron, State Sanatorium, Hospital for Balneotherapy, Balf, Hungary.
Martos
J
J
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000503:physiopathology / Q000628:therapy*; D010146:Pain / Q000503:physiopathology; D059408:Pain Management; D026741:Physical Therapy Modalities / Q000379:methods*; D011183:Postoperative Complications / Q000503:physiopathology / Q000628:therapy*; D016059:Range of Motion, Articular; D014049:Tolperisone / Q000494:pharmacology / Q000627:therapeutic use*
D014049:Tolperisone